CyberKnife S7 system (Image from Accuray)
Accuray (NSDQ:ARAY) announced today that it launched its CyberKnife S7 system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
Using real-time artificial intelligence-driven motion tracking and synchronization, CyberKnife S7 offers treatments for SRS and SBRT in as little as 15 minutes, according to a news release.
The system’s AI adapts radiation delivery to patient and/or tumor movement throughout the course of treatment while offering more positions from which radiation beams can be delivered, giving physicians the ability to maximize radiation doses to the tumor and minimize doses to the surrounding healthy tissues, according to a news release.
Sunnyvale, Calif.-based Accuray touts its next-generation system from the CyberKnife platform as capable of treating cancerous and benign tumors throughout the body, a…